Physician profile
Vincent A Viola
NPI 1225034796
$8,448.08
in general payments reported to CMS, 2019-2025
18 companies · $2,461 in 2025
The $2,461 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,574 · 2022: $1,375 · 2023: $1,329 · 2024: $1,709 · 2025: $2,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,401 · Travel and Lodging: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,401.08 |
| Travel and Lodging | $1,097.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,905.42 | 2021-2025 | Octrode, Proclaim, Eterna |
| Boston Scientific Corporation | $2,232.63 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Relievant Medsystems, INC. | $330.76 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $274.61 | 2023-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $234.09 | 2021-2023 | Mild Device Kit |
| Medtronic, INC. | $76.97 | 2022-2025 | Synchromedii |
| Nalu Medical, INC. | $67.83 | 2022-2024 | Nalu Neurostimulation System |
| Pacira Therapeutics, INC. | $58.56 | 2021 | |
| Spr Therapeutics, INC | $45.08 | 2023-2024 | Sprint Pns System |
| Stimwave Technologies Incorporated | $40.95 | 2022 | |
| Biodelivery Sciences International, INC. | $31.48 | 2021 | |
| Curonix LLC | $29.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Horizon Therapeutics Plc | $26.52 | 2021-2022 | |
| Avanos Medical | $23.09 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.49 | 2024 | Belbuca |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $17.48 | 2025 | |
| Arbor Pharmaceuticals, INC. | $17.14 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.68 | 2024 | Gps III Platelet Concentration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Viola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.